Richard C. Young & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-242,497
| Closed | -$19.1M | – | 76 |
|
|
2023
Q4 | $19.1M | Buy |
242,497
+3,295
| +1% | +$235K | 2.57% | 6 |
|
|
2023
Q3 | $16.7M | Buy |
239,202
+562
| +0.2% | +$39.8K | 2.38% | 10 |
|
|
2023
Q2 | $16.5M | Buy |
238,640
+3,755
| +2% | +$267K | 2.27% | 11 |
|
|
2023
Q1 | $17.5M | Sell |
234,885
-4,162
| -2% | -$349K | 2.4% | 8 |
|
|
2022
Q4 | $22.3M | Sell |
239,047
-615
| -0.3% | -$59.3K | 2.97% | 3 |
|
|
2022
Q3 | $22.9M | Sell |
239,662
-1,156
| -0.5% | -$114K | 3.5% | 3 |
|
|
2022
Q2 | $22.3M | Buy |
240,818
+1,858
| +0.8% | +$181K | 2.89% | 5 |
|
|
2022
Q1 | $24.2M | Sell |
238,960
-1,214
| -0.5% | -$128K | 3.09% | 4 |
|
|
2021
Q4 | $24.8M | Buy |
240,174
+195
| +0.1% | +$18K | 3.12% | 5 |
|
|
2021
Q3 | $20.4M | Buy |
239,979
+251
| +0.1% | +$21K | 2.8% | 6 |
|
|
2021
Q2 | $20M | Buy |
239,728
+3,633
| +2% | +$298K | 2.54% | 7 |
|
|
2021
Q1 | $17.8M | Buy |
236,095
+7,969
| +3% | +$580K | 2.36% | 10 |
|
|
2020
Q4 | $15.6M | Buy |
228,126
+6,684
| +3% | +$435K | 2.37% | 12 |
|
|
2020
Q3 | $12.9M | Buy |
221,442
+64,340
| +41% | +$4M | 2.08% | 15 |
|
|
2020
Q2 | $10.2M | Buy |
157,102
+347
| +0.2% | +$21.9K | 1.7% | 21 |
|
|
2020
Q1 | $9.3M | Buy |
156,755
+3,629
| +2% | +$242K | 1.8% | 21 |
|
|
2019
Q4 | $11.4M | Buy |
153,126
+3,433
| +2% | +$241K | 1.9% | 21 |
|
|
2019
Q3 | $9.44M | Buy |
149,693
+4,390
| +3% | +$260K | 1.7% | 23 |
|
|
2019
Q2 | $7.92M | Buy |
145,303
+8,872
| +7% | +$478K | 1.5% | 33 |
|
|
2019
Q1 | $7.36M | Buy |
136,431
+52,721
| +63% | +$3.25M | 1.4% | 32 |
|
|
2018
Q4 | $5.49M | Sell |
83,710
-974
| -1% | -$72.7K | 1.17% | 32 |
|
|
2018
Q3 | $6.67M | Buy |
84,684
+1,231
| +1% | +$88K | 1.27% | 30 |
|
|
2018
Q2 | $5.37M | Sell |
83,453
-446
| -0.5% | -$29.4K | 1.08% | 35 |
|
|
2018
Q1 | $5.22M | Buy |
83,899
+2,657
| +3% | +$191K | 1.04% | 36 |
|
|
2017
Q4 | $5.89M | Sell |
81,242
-8,181
| -9% | -$595K | 1.11% | 38 |
|
|
2017
Q3 | $7.27M | Buy |
89,423
+2,880
| +3% | +$228K | 1.38% | 35 |
|
|
2017
Q2 | $6.96M | Buy |
86,543
+2,782
| +3% | +$220K | 1.36% | 36 |
|
|
2017
Q1 | $6.58M | Buy |
83,761
+11,522
| +16% | +$920K | 1.3% | 37 |
|
|
2016
Q4 | $5.7M | Buy |
72,239
+3,762
| +5% | +$304K | 1.2% | 38 |
|
|
2016
Q3 | $6.09M | Buy |
68,477
+1,124
| +2% | +$106K | 1.32% | 35 |
|
|
2016
Q2 | $6.45M | Buy |
67,353
+581
| +0.9% | +$57.9K | 1.43% | 33 |
|
|
2016
Q1 | $6.93M | Buy |
66,772
+11,165
| +20% | +$1.09M | 1.56% | 31 |
|
|
2015
Q4 | $5.44M | Buy |
55,607
+8,861
| +19% | +$868K | 1.24% | 38 |
|
|
2015
Q3 | $4.51M | Buy |
46,746
+2,128
| +5% | +$224K | 1.12% | 42 |
|
|
2015
Q2 | $4.68M | Buy |
44,618
+2,206
| +5% | +$225K | 1.06% | 41 |
|
|
2015
Q1 | $4.38M | Buy |
+42,412
| New | +$4.29M | 0.96% | 44 |
|
Other funds holding CVS
Richard C. Young & Co's CVS Position: Q1 2024 in Review
Richard C. Young & Co sold out of CVS Health (CVS) in Q1 2024, closing a stake of 242,497 shares — an estimated $19.1M sold.
Richard C. Young & Co first reported a position in CVS in Q1 2015 and held it in 36 quarters. The position peaked at $24.8M in Q4 2021. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.
- Richard C. Young & Co reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
- Richard C. Young & Co sold 242,497 CVS Health shares in Q1 2024, an estimated $19.1M.
- Richard C. Young & Co first reported a position in CVS Health in Q1 2015 and held it in 36 quarters.
- Richard C. Young & Co's CVS Health position peaked at $24.8M in Q4 2021.
- 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.
Based on Richard C. Young & Co's 13F filing for Q1 2024, filed 8 May 2024.